Home

PB Ratio of Concord Drugs Ltd

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

PB Ratio

2

Last updated on: Sep 17, 2025

Key Highlights

  • The latest PB Ratio of Concord Drugs Ltd is 2.
  • The PB ratio of the Concord Drugs Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Concord Drugs Ltd changed from 0.9 on March 2022 to 1 on March 2024 . This represents a CAGR of 3.57% over 3 years.

Historical P/B Ratio of Concord Drugs Ltd

No data available

Company Fundamentals for Concord Drugs Ltd

Market Cap

68 Cr

EPS

0.4

P/E Ratio (TTM)

159.4

P/B Ratio (TTM)

2.0

Day’s High

67.18

Day’s Low

67.18

DTE

0.5

ROE

1.0

52 Week High

71.0

52 Week Low

26.1

ROCE

5.3

Market Price of Concord Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Sep 202568.55
16 Sep 202569.93
15 Sep 202569
12 Sep 202568.6
11 Sep 202570
10 Sep 202568.66
09 Sep 202567.32
08 Sep 202566
05 Sep 202565.25
04 Sep 202564

SWOT Analysis

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Concord Drugs Ltd

Asset Value vs Market Value of Concord Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PB Ratio of Concord Drugs Ltd Explained

68.55

Market cap

34

Book Value per Share

2.0X

PB Ratio

Historical Market Cap of Concord Drugs Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Concord Drugs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Concord Drugs Ltd News Hub

Concord Drugs consolidated net profit declines 93.88% in the June 2024 quarter

Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as again

Read more

10 Aug 24

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered

Read more

06 Aug 24

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September 2024. Powe

Read more

03 Sept 24

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 Sept

Read more

19 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Concord Drugs Ltd

What is the PB ratio of Concord Drugs Ltd?

The current PB ratio of Concord Drugs Ltd is 2.01. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Concord Drugs Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Concord Drugs Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Concord Drugs Ltd calculated?

The PB ratio of Concord Drugs Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Concord Drugs Ltd?

A high PB ratio suggests that Concord Drugs Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Concord Drugs Ltd?

A low PB ratio of Concord Drugs Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Concord Drugs Ltd PB Ratio change over time?

Yes, the PB ratio of Concord Drugs Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions